Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-02

Clinical Trial Update: Levetiracetam to Prevent Post-Traumatic Epilepsy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating levetiracetam to prevent post-traumatic epilepsy has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Pavel Klein | Conditions: Epilepsy, Post-traumatic Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2015-11-02